Co-expression analysis using anti-TUSC3 and anti-p53 antibodies showed that there was significant correlation between those in the lymph node metastasized lung cancer patient samples (Fig. 4j and Supplementary Fig. 8j). Here, TP53 is linked to lung cancer.